Clinical Trial Update: A Phase II, Repeat Single Oral Dose Study of IPED2015 in Healthy Male Subjects With Erectile Dysfunction [Phase 2]

View source ↗

Summary

Phase II repeat-dose study in healthy male subjects with erectile dysfunction is ongoing; results not yet reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erectile Dysfunction

Snippet

Sponsor: Initiator Pharma | Conditions: Erectile Dysfunction | Phase 2 | Status: UNKNOWN